1. Home
  2. SGC vs CRDF Comparison

SGC vs CRDF Comparison

Compare SGC & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Superior Group of Companies Inc.

SGC

Superior Group of Companies Inc.

HOLD

Current Price

$9.98

Market Cap

157.7M

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.79

Market Cap

130.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGC
CRDF
Founded
1920
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.7M
130.7M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
SGC
CRDF
Price
$9.98
$1.79
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$16.00
$9.63
AVG Volume (30 Days)
36.6K
689.6K
Earning Date
03-03-2026
05-07-2026
Dividend Yield
5.47%
N/A
EPS Growth
N/A
27.37
EPS
0.46
N/A
Revenue
$566,184,000.00
$365,993.00
Revenue This Year
$3.23
N/A
Revenue Next Year
$3.82
N/A
P/E Ratio
$22.35
N/A
Revenue Growth
0.09
49.61
52 Week Low
$8.30
$1.48
52 Week High
$13.78
$4.56

Technical Indicators

Market Signals
Indicator
SGC
CRDF
Relative Strength Index (RSI) 47.30 43.24
Support Level $9.73 $1.51
Resistance Level $10.49 $2.05
Average True Range (ATR) 0.42 0.12
MACD -0.02 0.00
Stochastic Oscillator 23.47 16.92

Price Performance

Historical Comparison
SGC
CRDF

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Share on Social Networks: